Related Experiment Videos
CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice
Jun-Qi Yang1, Taehoon Chun, Hongzhu Liu
1Autoimmunity and Tolerance Laboratory, Department of Internal Medicine, University of Cincinnati, and Veterans Affairs Medical Center, Cincinnati, Ohio 45267, USA.
European Journal of Immunology
|May 27, 2004
Summary
CD1d deficiency exacerbates inflammatory skin disease in lupus-prone mice, increasing immune cell infiltration and altering cytokine profiles. This highlights CD1d's regulatory role in autoimmune dermatitis.
Area of Science:
- Immunology
- Dermatology
- Autoimmune Diseases
Background:
- Mechanisms of lupus-related autoimmune skin disease are not fully understood.
- CD1d is an antigen-presenting molecule that activates natural killer T cells.
Purpose of the Study:
- Investigate the role of CD1d in the development of inflammatory dermatitis in lupus-susceptible MRL-lpr/lpr mice.
- Determine the impact of CD1d deficiency on skin disease severity and immune cell infiltration.
Main Methods:
- Generated CD1d-deficient MRL-lpr/lpr mice.
- Compared skin disease, immune cell infiltration, and cytokine production between CD1d-deficient and wild-type mice.
Main Results:
- CD1d-deficient mice exhibited more frequent and severe skin disease.
- Increased infiltration of mast cells, lymphocytes, and dendritic cells (including Langerhans cells) was observed in CD1d-deficient mice.
- Altered T cell populations and cytokine profiles (decreased type 2, increased/unchanged type 1) were associated with CD1d deficiency.
Conclusions:
- CD1d plays a regulatory role in inflammatory dermatitis.
- CD1d deficiency contributes to autoimmune skin disease pathogenesis through T cell expansion and altered cytokine production.